Literature DB >> 19656844

Successful treatment of childhood cutaneous leishmaniasis with liposomal amphotericin B: report of two cases.

Teresa del Rosal1, Fernando Baquero Artigao, Maria J Garcia Miguel, Raul de Lucas, Fernando del Castillo.   

Abstract

Treatment of cutaneous leishmaniasis is sometimes difficult. No single ideal therapy has yet been identified and some of the drugs that are currently used are associated with significant toxicity. We present two cases of cutaneous leishmaniasis in children, one caused by Leishmania infantum and the other by Leishmania braziliensis. Both of them were successfully treated with intravenous liposomal amphotericin B.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19656844     DOI： 10.1093/tropej/fmp073

Source DB:  PubMed          Journal:  J Trop Pediatr        ISSN： 0142-6338            Impact factor:   1.165


  7 in total

1.  Lipsosomal amphotericin B for treatment of cutaneous leishmaniasis.

Authors:  Glenn Wortmann; Michael Zapor; Roseanne Ressner; Susan Fraser; Josh Hartzell; Joseph Pierson; Amy Weintrob; Alan Magill
Journal:  Am J Trop Med Hyg       Date:  2010-11       Impact factor: 2.345

Review 2.  Therapeutic options for old world cutaneous leishmaniasis and new world cutaneous and mucocutaneous leishmaniasis.

Authors:  Begoña Monge-Maillo; Rogelio López-Vélez
Journal:  Drugs       Date:  2013-11       Impact factor: 9.546

3.  A species-specific approach to the use of non-antimony treatments for cutaneous leishmaniasis.

Authors:  Roshan Ramanathan; Kawsar R Talaat; Daniel P Fedorko; Siddhartha Mahanty; Theodore E Nash
Journal:  Am J Trop Med Hyg       Date:  2011-01       Impact factor: 2.345

4.  Central nervous system toxicity associated with liposomal amphotericin B therapy for cutaneous leishmaniasis.

Authors:  Jessie S Glasser; Clinton K Murray
Journal:  Am J Trop Med Hyg       Date:  2011-04       Impact factor: 2.345

5.  Amphotericin B resistance in Leishmania mexicana: Alterations to sterol metabolism and oxidative stress response.

Authors:  Edubiel A Alpizar-Sosa; Nur Raihana Binti Ithnin; Wenbin Wei; Andrew W Pountain; Stefan K Weidt; Anne M Donachie; Ryan Ritchie; Emily A Dickie; Richard J S Burchmore; Paul W Denny; Michael P Barrett
Journal:  PLoS Negl Trop Dis       Date:  2022-09-28

6.  Bismuth(III) α-hydroxy carboxylates: highly selective toxicity of glycolates towards Leishmania major.

Authors:  Allan Loh; Yih Ching Ong; Victoria L Blair; Lukasz Kedzierski; Philip C Andrews
Journal:  J Biol Inorg Chem       Date:  2015-09-28       Impact factor: 3.358

7.  Liposomal amphotericin B in travelers with cutaneous and muco-cutaneous leishmaniasis: Not a panacea.

Authors:  Romain Guery; Benoit Henry; Guillaume Martin-Blondel; Claire Rouzaud; Florence Cordoliani; Gundel Harms; Jean-Pierre Gangneux; Françoise Foulet; Emmanuelle Bourrat; Michel Baccard; Gloria Morizot; Paul-Henri Consigny; Antoine Berry; Johannes Blum; Olivier Lortholary; Pierre Buffet
Journal:  PLoS Negl Trop Dis       Date:  2017-11-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.